英文名稱 Anti-CARD8

中文名稱 凋亡加強結(jié)構(gòu)域蛋白8抗體

濃 度 1mg/1ml

規(guī) 格 0.1ml/200μg

抗體來源 Rabbit

克隆類型 polyclonal

交叉反應(yīng) Human

產(chǎn)品類型 一抗

研究領(lǐng)域 細胞生物 細胞凋亡

蛋白分子量 predicted molecular weight: 49kDa

性 狀 Lyophilized or Liquid

免 疫 原 KLH conjugated synthetic peptide derived from humanCARD8

亞 型 IgG

純化方法 affinity purified by Protein A

儲 存 液 Preservative: 15mM Soium zde, Constituents: 1% BSA,0.01M PBS, pH 7.4

產(chǎn)品應(yīng)用 WB=1:100-500 ELISA=1:500-1000 IP=1:20-100IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500

（石蠟切片需做抗原修復(fù)）

not yet tested in other applications.

optimal dilutions/concentrations should be determined by theend user.

保存條件 Store at -615 °C for oneyear.

別 名 Apoptotic protein NDPP 1; Apoptotic protein NDPP1;CARD 8; CARD inhibitor of NF kappa B activating ligand; CARD inhibitor of NFkappaB activating ligand; CARD inhibitor of NF kappaB activating ligands;CARD-inhibitor of NF-kappa-B-activating ligand; CARD8; CARD8_HUMAN; CARDINAL;Caspase recruitment domain containing protein 8; Caspase recruitment domainfamily member 8; Caspase recruitment domain protein 8; Caspase recruitmentdomain-containing protein 8; DACAR; NDPP 1; NDPP1; TUCAN; Tumor up regulatedCARD containing antagonist of CASP9; Tumor up regulated CARD containingantagonist of caspase 9; Tumor up-regulated CARD-containing antagonist ofCASP9; Tumor upregulated CARD containing antagonist of CASP9.